These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29283926)

  • 1. Interactions of Propofol With Human Voltage-gated Kv1.5 Channel Determined by Docking Simulation and Mutagenesis Analyses.
    Kojima A; Fukushima Y; Ito Y; Ding WG; Ueda R; Seto T; Kitagawa H; Matsuura H
    J Cardiovasc Pharmacol; 2018 Jan; 71(1):10-18. PubMed ID: 29283926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Verapamil Binding Sites Within Human Kv1.5 Channel Using Mutagenesis and Docking Simulation.
    Ding WG; Tano A; Mi X; Kojima A; Seto T; Matsuura H
    Cell Physiol Biochem; 2019; 52(2):302-314. PubMed ID: 30816676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
    Kojima A; Ito Y; Ding WG; Kitagawa H; Matsuura H
    Eur J Pharmacol; 2015 Oct; 764():622-632. PubMed ID: 26256861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum albumin attenuates the open-channel blocking effects of propofol on the human Kv1.5 channel.
    Kojima A; Bai JY; Ito Y; Ding WG; Kitagawa H; Matsuura H
    Eur J Pharmacol; 2016 Jul; 783():117-26. PubMed ID: 27164421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory actions of the phosphatidylinositol 3-kinase inhibitor LY294002 on the human Kv1.5 channel.
    Wu J; Ding WG; Matsuura H; Tsuji K; Zang WJ; Horie M
    Br J Pharmacol; 2009 Jan; 156(2):377-87. PubMed ID: 19154427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain.
    Wu HJ; Wu W; Sun HY; Qin GW; Wang HB; Wang P; Yalamanchili HK; Wang J; Tse HF; Lau CP; Vanhoutte PM; Li GR
    J Mol Cell Cardiol; 2011 Dec; 51(6):966-73. PubMed ID: 21906601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic Aspects of Verapamil Binding (On-Rate) on Wild-Type and Six hKv1.3 Mutant Channels.
    Diesch AK; Grissmer S
    Cell Physiol Biochem; 2017; 44(1):172-184. PubMed ID: 29131061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The molecular basis of high-affinity binding of the antiarrhythmic compound vernakalant (RSD1235) to Kv1.5 channels.
    Eldstrom J; Wang Z; Xu H; Pourrier M; Ezrin A; Gibson K; Fedida D
    Mol Pharmacol; 2007 Dec; 72(6):1522-34. PubMed ID: 17872968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of human cardiac Kv1.5 channels by extracellular acidification.
    Wang S; Ding WG; Bai JY; Toyoda F; Wei MJ; Matsuura H
    Pflugers Arch; 2016 Nov; 468(11-12):1885-1894. PubMed ID: 27796577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding site of a novel Kv1.5 blocker: a "foot in the door" against atrial fibrillation.
    Decher N; Kumar P; Gonzalez T; Pirard B; Sanguinetti MC
    Mol Pharmacol; 2006 Oct; 70(4):1204-11. PubMed ID: 16835355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.
    Gong YZ; Ding WG; Wu J; Tsuji K; Horie M; Matsuura H
    Eur J Pharmacol; 2008 Dec; 600(1-3):18-25. PubMed ID: 18930721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels.
    Decher N; Pirard B; Bundis F; Peukert S; Baringhaus KH; Busch AE; Steinmeyer K; Sanguinetti MC
    J Biol Chem; 2004 Jan; 279(1):394-400. PubMed ID: 14578345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open channel block of Kv1.5 channels by HMQ1611.
    Dong C; Li J; Ding W; Ueda R; Xie X; Wu J; Matsuura H; Horie M
    Front Pharmacol; 2022; 13():965086. PubMed ID: 36188606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
    Decher N; Kumar P; Gonzalez T; Renigunta V; Sanguinetti MC
    Mol Pharmacol; 2005 Oct; 68(4):995-1005. PubMed ID: 16024663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the σ-Pore in Mutant hKv1.3 Potassium Channels.
    Tyutyaev P; Grissmer S
    Cell Physiol Biochem; 2018; 46(3):1112-1121. PubMed ID: 29669325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of potent Kv1.5 potassium channel inhibitors reveals the molecular basis for blocking kinetics and binding mode.
    Strutz-Seebohm N; Gutcher I; Decher N; Steinmeyer K; Lang F; Seebohm G
    Cell Physiol Biochem; 2007; 20(6):791-800. PubMed ID: 17982261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis involved in the blocking effect of antidepressant metergoline on C-type inactivation of Kv1.4 channel.
    Bai HW; Eom S; Yeom HD; Nguyen KVA; Lee J; Sohn SO; Lee JH
    Neuropharmacology; 2019 Mar; 146():65-73. PubMed ID: 30465811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Open-channel blocking action of volatile anaesthetics desflurane and sevoflurane on human voltage-gated K
    Fukushima Y; Kojima A; Mi X; Ding WG; Kitagawa H; Matsuura H
    Br J Pharmacol; 2020 Aug; 177(16):3811-3827. PubMed ID: 32436224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment.
    Yang L; Ma JH; Zhang PH; Zou AR; Tu DN
    Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):154-61. PubMed ID: 18986330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Putative binding sites for arachidonic acid on the human cardiac Kv 1.5 channel.
    Bai JY; Ding WG; Kojima A; Seto T; Matsuura H
    Br J Pharmacol; 2015 Nov; 172(22):5281-92. PubMed ID: 26292661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.